ALS News & Research For postings of news or research links and articles related to ALS


advertisement
Reply
 
Thread Tools Display Modes
Old 05-02-2017, 09:24 PM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
Lightbulb Biohaven Advances Regulatory Efforts for BHV-0223, a Sublingual Form of ALS Therapy R

Biohaven Advances Regulatory Efforts for BHV-0223, a Sublingual Form of ALS Therapy Rilutek

ALS Therapy Rilutek's Sublingual Version BHV-223 is Focus of Biohaven Regulatory Efforts
MuonOne is offline   Reply With QuoteReply With Quote

advertisement
Reply

Tags
als, biohaven, form, sublingual, therapy


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Biohaven Pharmaceutical files for IPO MuonOne ALS News & Research 0 05-01-2017 09:54 PM
Biohaven Announces Orphan Drug Designation Request Granted For BHV-0223 In The Treatm MuonOne ALS News & Research 0 12-08-2016 01:26 PM
advances-and-challenges-in-the-dosage-form-design-for-the-treatment-of-parkinson soccertese Parkinson's Disease 0 06-19-2013 10:42 AM


All times are GMT -5. The time now is 09:24 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.